In the phase 1/2 INSPIRE DUCHENNE trial, interim data showed an average microdystrophin expression of 110% among participants ...
12h
GlobalData on MSNWhole genome sequencing poised to transform newborn screening programmesNewborn screening is transforming, as advances in genomic sequencing pave the way for earlier, more accurate diagnoses of ...
It was a busy week for the biotech sector. While the fourth-quarter earnings season is nearing the end, other pipeline and regulatory updates were in focus. Recap of the Week’s ...
13h
Zacks.com on MSNBiotech Stock Roundup: BLUE Down on Update, News From GILD, TRDAIt was a busy week for the biotech sector. While the fourth-quarter earnings season is nearing the end, other pipeline and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results